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Nanoparticles (NPs) show new characteristics compared to the corresponding bulk
material. These nanoscale properties make them interesting for various applications in
biomedicine and life sciences. One field of application is the use of magnetic NPs to
support regeneration in the nervous system. Drug delivery requires a functionalization of
NPs with bio-functional molecules. In our study, we functionalized self-made PEI-coated
iron oxide NPs with nerve growth factor (NGF) and glial cell-line derived neurotrophic
factor (GDNF). Next, we tested the bio-functionality of NGF in a rat pheochromocytoma
cell line (PC12) and the bio-functionality of GDNF in an organotypic spinal cord
culture. Covalent binding of NGF to PEI-NPs impaired bio-functionality of NGF, but
non-covalent approach differentiated PC12 cells reliably. Non-covalent binding of GDNF
showed a satisfying bio-functionality of GDNF:PEI-NPs, but turned out to be unstable
in conjugation to the PEI-NPs. Taken together, our study showed the importance of
assessing bio-functionality and binding stability of functionalized growth factors using
proper biological models. It also shows that successful functionalization of magnetic NPs
with growth factors is dependent on the used binding chemistry and that it is hardly
predictable. For use as therapeutics, functionalization strategies have to be reproducible
and future studies are needed.
Keywords: functionalization, nanoparticles, glial cell-line derived neurotrophic factor (GDNF), nerve growth factor
(NGF), organotypic spinal cord culture, PC12 cells
Introduction
Nanoparticles (NPs) are materials that display different characteristics at the nanoscale than
the corresponding bulk material. Usually, the term NP is used for substances with sizes
about 1–100 nm, but there is an ongoing discussion about using the term NPs in a more
Abbreviations: BSA, bovine serum albumin; BDNF, brain-derived growth factor; CNS, central nervous system; FBS,
fetal bovine serum; GFR-α, GDNF family receptor-α; GDNF, glial cell-line derived neurotrophic factor; MRI, magnetic
resonance imaging, MAPK, mitogen-activated protein kinase; NPs, nanoparticles; NGF, nerve growth factor; PNS, peripheral
nervous system; PBS, phosphate buffered saline; PI3K, phosphatidylinositol 3-kinase; PLCγ, phospholipase Cγ; PEI,
polyethyleneimine; PC12, rat pheochromocytoma cell line; TrkA, tropomyosin receptor kinase A.
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size-independent way, referring more to the occurrence of
new properties or the high ratio of surface area to volume
(Kreyling et al., 2010). One feature that changes with nanoscale
is magnetism. Iron is a ferromagnetic bulk material, however
reducing its size to the nanoscale results in superparamagnetic
behavior. Superparamagnetic NPs are non-magnetic until they
are exposed to a strong magnetic field. If the magnetic field is
removed, they revert to a non-magnetic state again (Mortimer
and Müller, 2003; Estelrich et al., 2015). In the case of magnetite
Fe3O4 and maghemite γ-Fe2O3, which are commonly used iron
oxide NPs, the superparamagnetic diameter is 25 nm (Fe3O4)
and 30 nm (γ-Fe2O3). Both iron oxides are highly used in
biomedicine due to their stability, relatively low toxicity, and high
magnetization.
Superparamagnetic iron oxide NPs can be used in diagnostic
magnetic resonance imaging (MRI), e.g., Resovist R© underwent
successfully clinical trials and is used to enhance the contrast in
MRI scans of the liver (Reimer and Balzer, 2003; Weinstein et al.,
2010). In addition to tissue imaging, magnetic NPs are also used
to track cells with the MRI in vivo (Dunning, 2004; Antonelli
et al., 2013).
In cancer treatment, superparamagnetic NPs are used to
induce hyperthermia in prostate cancer and glioblastoma (Jordan
et al., 2001; Thiesen and Jordan, 2008). NPs are injected directly
into tumor tissue and stimulated with an alternating magnetic
field. This causes the particles to heat up, thereby destroying the
tumor tissue.
To localize functionalized magnetic NPs within a tissue
of interest, a static magnetic field can be applied. Chertok
et al. (2008) followed intravenously injected NPs in rats with
glioblastoma via MRI and showed an accumulation of NPs in the
tumors. Cells can also be targeted magnetically. Hamasaki et al.
(2007) labeled neural progenitor cells with magnetic NPs and
localized them in an organotypic co-culture with the help of an
external magnetic field. Corticospinal axon growth was improved
by magnetically targeted neural progenitor cells in comparison
to non-labeled cells. Labeling cells with magnetic NPs can also
help to purify primary cell cultures. Gordon et al. (2011) used
magnetic NPs to purify microglia from mixed primary glial
cultures.
The magnetofection technique uses magnetic force to deliver
nucleic acids or viruses into cells. By applying a strong external
magnetic field, cells can be transfected with superparamagnetic
NPs, which are functionalized with gene vectors (Scherer et al.,
2002). Magnetofection offers a simple method to transfect cells
that are normally difficult to transfect, e.g., cells of the central
nervous system (CNS). Efficient transfection was achieved in
primary neural stem cells (Sapet et al., 2011), oligodendrocyte
precursor cells (Jenkins et al., 2011), hippocampal neurons
(Buerli et al., 2007), and astrocytes (Pickard and Chari, 2010).
Also primary motor neurons could be transfected using this
method. Fallini et al. (2010) transfected primary motor neurons
with NPs functionalized with GFP-expressing plasmids. Motor
neurons showed no signs of cytotoxicity and about 45% of cells
could be transfected.
Magnetic NPs have a large surface-to-volume ratio that
enables chemical conjugation and changes the surface properties
of the NPs. Usually; they are synthesized by wet chemistry
approaches, which produce Ferro fluid water dispersions (Vergés
et al., 2008). The stability of Ferro fluids depends on the
equilibrium between dipole-dipole interactions among particles
and particle-solvent interactions. In order to decrease the
strength of dipole-dipole interactions and stabilize the water
dispersion of NPs as single particles or small clusters, a surface
coating is required. The coating increases the hydrodynamic
ratio of the particles, which decreases magnetic interactions
among particles, stabilizing the dispersion. Additionally, surface
properties affect biocompatibility, particle opsonization in
biological media (Tenzer et al., 2013), cellular internalization
mechanisms, and biological interactions (Gao et al., 2009;
Veiseh et al., 2010). For coating, organic polymers (dextran,
chitosan, polyethylene glycol), inorganic substances (gold, silica,
carbon), and bioactive molecules (liposomes, proteins, ligands)
can be used (Shubayev et al., 2009; Estelrich et al., 2015). The
functionalization with bioactive groups and proteins allows a
wide range of applications, particularly in life sciences (Pankhurst
et al., 2003; Gupta and Gupta, 2005). Drug delivery is one
application of interest (Arruebo et al., 2007; Estelrich et al.,
2015). Huang et al. (2015a) described layer-by-layer casein-
coated magnetic NPs, which could be loaded with doxorubicin
and indocyanine green. NPs were stable under gastric conditions
and drugs were released by degradation of the casein in the
intestine. Nazli et al. (2014) showed that doxorubicin-delivery by
MMP-sensitive PEG hydrogel-coated magnetic NPs are taken up
efficiently into HeLa cells and the drug released within 2 h.
In neurosciences, magnetic NPs have received attention in the
fields of CNS and peripheral nervous system (PNS) regeneration.
Injury to the nervous system produces high costs for the health
systems, partially due to massive lifelong impairments (Noble
et al., 1998; Wyndaele and Wyndaele, 2006) and therefore is still
a highly interesting field of investigation.
In CNS injury, one distinguishes between primary and
secondary injury. The primary injury results from mechanical
forces, damaging cells at the injury site. Due to secondary
processes the size of the injury is increased and damage is
prolonged. Tissue is additionally damaged by ischemia, edema,
excitotoxicity, shifting of ion concentrations, production
of reactive oxygen species, inflammation, necrosis, and
demyelination of axons (Salewski et al., 2013; Siddique and
Thakor, 2014).
Regeneration in the CNS is a huge challenge. One reason
for this is the complex glial composition of the CNS:
astroglia, microglia, and oligodendroglia. The inhibition of
oligodendroglia and its apoptosis after loss of axon contact
(Beattie et al., 2000; Vargas and Barres, 2007), the activation of
microglia, which secrete pro-inflammatory cytokines (Danton
and Dietrich, 2003), and the activation of astroglia, which
results in the formation of a glia scarring in the injured
area, are producing a regeneration-inhibiting environment
making regeneration impossible (Fawcett and Asher, 1999;
Fitch and Silver, 2008). In addition to surgical therapies,
therapy approaches often try to modulate inflammatory actions,
e.g., using minocycline or methylprednisolone (McDonald and
Sadowsky, 2002; Beattie, 2004; Stahel et al., 2012). Studies trying
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to influence the glial scar and the regeneration-inhibiting features
of residual myelin are done, too (Kwon et al., 2011). Nevertheless,
neurons of the CNS have the capacity to regenerate, which was
demonstrated by mixing CNS and PNS tissue/cells. In a mixed
milieu, CNS neurons can regenerate into a PNS environment
(David and Aguayo, 1981; Pearse et al., 2004).
In contrast, the potential for regeneration in the peripheral
nervous system is, in principle, good (Navarro et al., 2007; Vargas
and Barres, 2007; Svennigsen and Dahlin, 2013). After axon
injury in the peripheral nerve several processes of degeneration
and regeneration start. The injured neuron undergoes changes
in metabolism and protein expression after retrograde signaling
and calcium influx at the lesioned axon. Chromatolysis occurs
and regeneration-related proteins like growth-associated protein
43 are upregulated. Growth cones are formed and elongate
following guidance molecules provided by activated Schwann
cells (Dent et al., 2003; Bradke et al., 2012; Patodia and
Raivich, 2012). Schwann cells are activated by losing axonal
contact and interruption of blood and oxygen supply. Calcium
signaling activates intracellular cascades including mitogen-
activated protein kinases (MAPK), like the extracellular signal-
regulated protein kinases (ERK1/2), and c-jun N-terminal
protein kinases (JNK1/2/3) (Agthong et al., 2006; Chattopadhyay
and Shubayev, 2009; Yamazaki et al., 2009; Arthur-Farraj et al.,
2012). These signaling cascades result in a termination of myelin
production, dedifferentiation, and then proliferation of Schwann
cells at the distal injury site. Schwann cells start phagocytosis of
myelin and cell debris before macrophages enter the injury site
time-delayed. Schwann cells then start to produce regeneration-
promoting factors, like nerve growth factor (NGF), brain-derived
growth factor (BDNF), and glial cell-line derived neurotrophic
factor (GDNF) (Funakoshi et al., 1993; Xu et al., 2013; Huang
et al., 2015b), and align to regular structures, e.g., the Bands
of Büngner, which guide regenerating axons to reinnervate
their targets. Altogether, Schwann cells help to establish a
regeneration-permissive environment for the regenerating axon.
Nevertheless, the regenerative outcome in the PNS is poor.
Only 40% of patients regain a normal functionality, 16% show a
good functional outcome, whereas 32% of the patients show little
improvement, and 12% even show a complete loss of function
(Noble et al., 1998). The clinical strategies used to treat patients
with peripheral nerve injury have not improved in the last years.
Surgery is still the treatment of choice (Scholz et al., 2009). Direct
end-to-end repair avoiding tensions shows the best outcome. If
tensionless repair is not possible, grafting or conduits are chosen
to bridge the gap between the nerve endings. Often sensory
nerves from the patient (autograft) or from donors (allograft)
are used as grafts. Blood vessels are usually used as biological
conduits. Collagen, polyglycolic acid, and caprolactone conduits
are also available (Dahlin, 2008; Griffin et al., 2013; Grinsell and
Keating, 2014).
One problem, even after successful surgery, is the non-specific
reinnervation of target organs due to randomly axonal sprouting
andmisdirection of regenerating axons. Additionally, projections
in the CNS are lost after an injury and new synaptic contacts need
a rebuilding of CNS projections and a long-term learning process
(Navarro et al., 2007; de Ruiter et al., 2014).
Magnetic NPs now offer a new possibility to promote PNS
regeneration. One idea is to facilitate the uptake of magnetic
NPs in regenerating neurons and their axons and to pull the
axon along an external magnetic field. Therefore, the guidance of
sprouting axons is promoted and the specificity of reinnervation
is enhanced (Halpern, 2000; Riggio et al., 2012; Calatayud et al.,
2013; Goya et al., 2014; Riggio et al., 2014). Previous studies
showed initial success. Human neuroblastoma (SH-SY5Y) cells
were effectively influenced by an external magnetic field after
magnetic NPs uptake. Also primary Schwann cells and olfactory
ensheating cells showed satisfying uptake of NPs and could
be moved along a magnetic field (Riggio et al., 2012, 2013).
Neurite orientation was shown to be directed toward a magnetic
force after uptake of magnetic NPs into differentiated PC12 cells
(Riggio et al., 2014).
However, peripheral nerve injury is more complicated. To
facilitate regeneration of injured axons, NPs have to be taken
up into neurons. Primary neuronal cells in mixed cell cultures
showed relatively low uptake of iron oxide NPs (Pinkernelle et al.,
2012). Petters and Dringen (2015) showed that using serum-
containingmedia significantly lowers the uptake of magnetic iron
oxide NPs in cerebellar granule neurons compared to serum-
free media. NPs diluted in serum-containing media develop a
protein corona, which seems to impede the efficient uptake of
NPs in neurons. There are various strategies to enhance neuronal
uptake. Adams et al. (2015) increased magnetite content of NPs
using sedimenting forces. Buerli et al. (2007) and Fallini et al.
(2010) used magnetofection to promote uptake into neurons
and transfected them with DNA. Another possibility is the
coupling of growth factors, which utilize receptor-mediated
uptake. Ziv-Polat et al. (2014) conjugated iron oxide NPs with
different neurotrophic factors. They showed that the stability of
neurotrophic factors in media and their functional activity was
improved by binding them to the NPs. Altogether coupling of
growth factors seems to be the most promising strategy in terms
of a future clinical approach.
In our study, we focus on 2 growth factors: NGF and GDNF.
Both play a role in PNS regeneration. NGF belongs to the
neurotrophin family binding to the tropomyosin receptor kinase
A (TrkA) or to p75 receptor (Boyd and Gordon, 2003). Most
studies concerning NGF were performed in PC12 cells, which
express both TrkA and p75 receptors. They can be differentiated
into neuronal-like cells displaying neurite development (Greene
and Tischler, 1976; Dichter et al., 1977). Signaling of Trk
receptors is mediated via the activation of phosphatidylinositol
3-kinase (PI3K), MAPK, and phospholipase Cγ (PLCγ). These
pathways regulate differentiation, survival, and neuritogenesis
(Boyd and Gordon, 2003).
GDNF is a neurotrophic factor belonging to the GDNF
family. These growth factors are secretory proteins and bind
to a receptor complex consisting of a high affinity ligand-
binding subunit, the GDNF family receptor-α (GFR-α), and a
signal transduction subunit RET receptor tyrosine kinase. GDNF
binds to GFR-α1 thereby activating RET, which leads to the
activation of the intracellular tyrosine kinase domain. PI3K,
MAPK, and PLCγ pathways are activated, regulating cell survival,
neurite outgrowth, and synaptic plasticity among other activities
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(Airaksinen and Saarma, 2002; Boyd and Gordon, 2003; Sariola
and Saarma, 2003).
We used self-made iron oxide NPs coated with
polyethyleneimine (PEI) for coupling growth factors (Calatayud
et al., 2013). PEI is a polymer, which is also used for the
transfection of cells (Vancha et al., 2004). It contains several
amine groups allowing covalent binding of proteins via peptide
bonds. First, we choose NGF for functionalization. NGF can
be internalized with its receptor (Neet and Campenot, 2001;
Matusica and Coulson, 2014) and therefore, coupling of NGF to
PEI-NPs should result in receptor-mediated uptake, increasing
the uptake rate of the NPs.
To check for bio-functionality of NGF after coupling to the
NPs, we used PC12 cells and induced the differentiation with the
help of our functionalized PEI-NPs. However, these cells cannot
be used to model the complex processes of neuronal injury and
regeneration. Because of this, we also used a neonatal organotypic
spinal cord model to resemble the regeneration of motor neurons
after axotomy (Pinkernelle et al., 2012, 2013; Keilhoff et al., 2014).
Organotypic cultures keep the cellular organization and the cell-
cell-contacts. Therefore, they model the in vivo environment
more accurately than disperse primary cell cultures or cell lines
(Stavridis et al., 2005; Pinkernelle et al., 2013). Proximal axotomy
was induced through the preparation of the spinal cord slices and
resulted in a loss of motor neurons. The trophic requirements
of motor neurons are still under discussion due to the variety
of factors needed and the wide range of cells providing them
(Oppenheim, 1996; Brunet et al., 2007).
GDNF is one of the most prominent neurotrophic factors
playing a role in both the survival of motor neurons and their
axonal regeneration (Bohn, 2004; Brunet et al., 2007; Vyas
et al., 2010; Pajenda et al., 2014). In organotypic spinal cord
cultures, a representative motor neuronal population of about
60% can be found after 1 week of cultivation with GDNF
supplement (Rakowicz et al., 2002; Vyas et al., 2010). Therefore,
we functionalized our self-made PEI-NPs with GDNF. Like
NGF, GDNF may be internalized via endocytosis together with
its receptor and moves anterogradely along axons (Neet and
Campenot, 2001; von Bartheld et al., 2001). In previous studies,
we found no reliable uptake of iron oxide NPs in primary motor
neurons and granular cells (Pinkernelle et al., 2012). Therefore,
we tried to facilitate the uptake of magnetic PEI-NPs with the
help of GDNF functionalization in order to obtain a receptor-
mediated uptake of NPs into the motor neurons of our spinal
cord model.
Materials and Methods
Cell Cultures
Cultivation
PC12 cells obtained from American Type Culture Collection
were cultured in Dulbecco’s modified Eagle’s media with 10%
horse serum, 5% fetal bovine serum (FBS), 100 IU/ml penicillin,
100µg/ml streptomycin, and 2mM L-glutamine. Cells were
cultivated in poly-L-lysine (Sigma, St. Louis, USA) coated dishes
and maintained at 37◦C in a saturated humidity atmosphere of
95% air and 5% CO2. For cell differentiation, PC12 cells were
incubated in serum-reduced media (2% FBS).
PC12 Actin Staining
The cytoskeletal arrangement of PC12 cells was studied by means
of actin staining. PC12 were seeded in Petri-dishes (for confocal
microscopy) at a concentration of 5× 105 cells/ml and incubated
overnight in growth media for cell adhesion. NGF:PEI-NPs were
added in reduced serum media at a concentration of 10µg/ml.
Cells were cultured for 3 days before staining.
The media was removed and the cells gently washed
with phosphate buffered saline (PBS) at 4◦C followed by
fixation/permeabilization with a solution of methanol: acetone
(1:1 v/v) at −20◦C for 30min. At the end of incubation, the cells
were washed 3x with PBS at 4◦C and incubated overnight at 4◦C
with the primary anti-actin antibody (1:200, rabbit polyclonal,
Santa Cruz Biotechnologies, Santa Cruz, USA). Then, the sample
was washed again 3x with PBS at 4◦C and incubated 1 h at room
temperature with the secondary antibody (1:100, goat anti-rabbit
IgG-TR, Santa Cruz Biotechnologies). Cells were washed 3x with
PBS, dried, and mounted. The images were analyzed by confocal
microscopy.
Electron Microscopy
Electron imaging was performed with a scanning electron
microscope (SEM INSPECT F50.FEI company) and dual-beam
(FIB/SEM. Helios 600.FEI company). SEM images were taken
at 5 and 30 kV with a FEG column and a combined Ga-based
30 kV (10 pA) ion beam was used to cross-section single cells.
The investigations were completed by energy-dispersive X-ray
spectroscopy (EDX) for chemical analysis. For this, PC12 cells
were seeded on glass coverslips (previously coated with poly-L-
lysine) at a density of 5 × 105 cells/ml. After cell adhesion, the
growth media was removed and replaced with the reduced media
containing the functionalized NPs (10µg/ml) or media with
corresponding NGF concentration. After 72 h of incubation, cells
were washed with PBS, fixed, dehydrated, dried, and sputtered
with 30 nm of gold for electron imaging.
Organotypic Spinal Cord Cultures and
Co-cultures
Animals
All animal studies were performed in accordance with the
guidelines of the German Animal Welfare Act. This study was
approved by the Animal Care and Use Committee of Saxony-
Anhalt, Germany. A formal approval to conduct the described
experiments was obtained from the Animal Subjects Review
Board of our institution and can be provided upon request. All
efforts were made to minimize the number of animals used and
their suffering.
Preparation and Cultivation
Organotypic cultures were prepared as described by Vyas
et al. (2010) with slight modifications. Neonatal rats (postnatal
day 4) were decapitated, and their spinal cords excised.
Spinal roots and meninges were removed in dissection buffer
(Hank’s balanced salt solution, 3.4mM NaHCO3, 10mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 33.3mM
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D-glucose, 5.8mM MgSO4, 0.03% bovine serum albumin
(BSA), 1% penicillin/streptomycin) and the lumbar spinal
cord (approximately L1-L6) was cut into 350µm transverse
sections using a McIlwain tissue chopper (Mickle Laboratory
Engineering, Gomshall, UK). 6–8 slices were used from 1
animal and distributed equal to all experimental groups. The
slices were cultured on Millicell membrane inserts (Millipore,
Billerica, USA) in 6-well plates. Each well contained 1ml of
media composed of 50% Eagle’s minimal essential media, 25%
Hank’s balanced salt solution, 25% FBS, 35mMD-glucose, 2mM
L-alanyl-L-glutamine, 1% penicillin/streptomycin. Cultures
maintained at 37◦C in a saturated humidity atmosphere of 95%
air and 5% CO2.
Culture preparation induces a loss of motor neurons due
to the proximal axotomy caused by the slicing. However, a
representative population of motor neurons (approximately
60%) can be found after 1 week in culture in the presence
of GDNF (R&D systems, Minneapolis, USA) (Rakowicz
et al., 2002; Vyas et al., 2010). Thus, control cultures
received GDNF treatment to stabilize the motor neuron
population.
Immunohistochemistry
Cultures were fixed after 1 week of cultivation by replacing the
media with 4% paraformaldehyde overnight. The membranes
of the Millicell inserts were separated from the carrier and
the cultures were stained free-floating. Slices were washed
3x with PBS. Non-specific binding sites were blocked with
10% FBS and 0.3% Triton-X100 in PBS for 1 h. Cultures
were incubated overnight with primary anti-pan-neurofilament
antibody (1:1000, mouse monoclonal, Sternberger Monoclonals,
Baltimore, USA) to visualize neurons including motor neurons
and neurites diluted in 10% FBS, 0.3% Triton-X100 in PBS.
Next, 3x washing with PBS was followed by secondary antibody
incubation for 3 h (1:250, goat anti-mouse Alexa 488, Invitrogen,
Carlsbad, USA). The slices were washed again and embedded
on glass slides with Immu-Mount (Thermo Scientific, Waltham,
USA).
Cultures were imaged with an AxioImager microscope and
analyzed with the AxioVision Rel. 4.8 Imaging software by Zeiss
(Jena, Germany). Themicroscopic settings and the exposure time
were set on the basis of control slices and kept equal for the
corresponding preparation.
Statistical analysis was performed using Graph Pad Prism 4
(GraphPad Software, La Jolla, USA).
Nanoparticles
Synthesis of PEI-NPs
Magnetic NPs synthesis is based on a modification of the well-
established oxidative hydrolysis method (i.e., the precipitation
of an iron salt in basic media with a mild oxidant) (Sugimoto
and Matijevic´, 1980). In situ polymer coating was achieved by
adding PEI (25 kDa) during the reaction, as described previously
(Calatayud et al., 2013). The particles exhibit a ferric oxide core
(about 25 nm in diameter) and a thin polymer coating of PEI
(about 0.7–0.9 nm); the total mass of PEI in the particles was
around 14% (w/w) and the amount of the PEI on the particle
surface was estimated 10 ± 2µg/mg of NPs (Calatayud et al.,
2013).
Preparation of NGF-PEI-NPs and NGF:PEI-NPs
NGF-β (Sigma, N1408) was marked with a fluorescent tag
by labeling a protein mixture of NGF/BSA (1:6 w/w) with
Alexa Fluor 488 (Life Technology, A-10235). TFP ester of
the dye efficiently reacted with primary amines of proteins.
Purification through a size exclusion resin allowed discarding
the unincorporated dye; 90% of the initial protein was labeled
with 1.5 moles of dye per mole of protein (n = 3).
In order to functionalize the particles with the fluorescent
NGF, 2 functionalization approaches were tested: covalent and
non-covalent. PEI groups exposed on the surface of PEI-
NPs offer primary and secondary amine-groups that have
been used to functionalize the particles with the labeled
protein.
In the covalent approach, the fluorescent NGF was attached to
PEI-NP via EDAC chemistry (Fluka 03450, Sigma, USA). Briefly
0.6mg EDAC and 1.2mg NHS were dissolved in 0.2ml 0.5M
MES-buffer (pH = 6.3) and added to 0.8ml of protein (NGF
concentration 35µg/ml). After a few minutes, 500µg of PEI-
NPs were added and mixed for 3 h at 4–8◦C. The unbounded
protein was removed by magnetic separation and discharging
the supernatant (3 washing steps). The NPs (thereafter labeled as
NGF-PEI-NPs) were resuspended in PBS.
The non-covalent approach consisted in adding an equal
volume of fluorescent protein (NGF concentration 35µg/ml) to
1mg/ml of PEI-NPs. The resulting suspension was dispersed at
room temperature for 3 h under stirring. Unbound protein was
removed bymagnetic separation and discharging the supernatant
(3 washing steps). The NPs (thereafter labeled as NGF:PEI-NPs)
were resuspended in PBS.
For both approaches, the amount of fluorescent NGF bound
to the surface of PEI-NPs was calculated by subtraction, i.e., by
measuring the absorbance at 280 nm of the supernatant derived
from the 3 washing steps. The concentration was calculated
by using a calibration curve obtained with known amounts of
fluorescent NGF. The composition of the sample was estimated
to be 500µg/ml of NPs, 7µg/ml of NGF.
Validation of NGF:PEI-NPs respectively NGF-PEI-NPs
For validation of the functionality of the NGF bound to the PEI-
NPs, PC12 cells were used as biological indicator. PC12 cells
were incubated in serum-reduced media for 72 h either with
NGF:PEI-NPs or NGF-PEI-NPs (NGF concentration 140 ng/ml,
NP concentration 10µg/ml) to induce differentiation of the cells
based on functionalized PEI-NPs.
Preparation of GDNF:PEI-NPs
For NP functionalization, a protein mixture of GDNF/BSA
(1:4 w/w, GDNF from Sigma Aldrich, USA) was labeled
with Alexa Fluor 488. Purification through a size exclusion
resin allowed discarding the unincorporated dye; 90% of the
initial protein was labeled with 1.5 moles of dye per mole
of protein (n = 3). The functionalization of the NPs was
carried out by adding the labeled protein (concentration
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of GDNF 35µg/ml) to PEI-NPs (500µg/ml). The resulting
suspension was dispersed at room temperature for 3 h under
stirring. Unbound protein was discarded (via magnetic
separation) and the functionalized NPs were resuspended
in 15% glycerol water solution to stabilize the product. The
composition of the sample was estimated to be 500µg/ml
of NPs, 2.8µg/ml of GDNF, 11.2µg/ml of BSA, 15% of
glycerol.
Validation of GDNF:PEI-NPs
To validate the functionality of GDNF bound to PEI-NPs,
we analyzed the survival of motor neurons of an organotypic
spinal cord culture as biological indicator. Cultures were divided
into 4 groups with 2 receiving GDNF supplemented to the
media (100 ng/ml or 50 ng/ml GDNF), another without any
GDNF supplement and 1 group cultivated with 10µg/ml
GDNF:PEI-NPs for the entire cultivation period of 1 week.
Spinal cord slices of the GDNF:PEI-NPs group were pre-
incubated for 30min on ice with 20µg/ml GDNF:PEI-NPs
diluted in preparation buffer to increase NP-uptake. Slices of
other groups were handled in parallel using preparation buffer
without NPs.
To validate the stability of GDNF:PEI-NPs in serum-high
media for spinal cord cultures, we pre-incubated 10µg/ml
GDNF:PEI-NPs in spinal cord media for 1 h at 4◦C. Afterwards,
GDNF:PEI-NPs were separated using a neodym magnet.
One group received this media supernatant for cultivation
(thereafter supernatant GDNF:PEI-NPs). The separated
GDNF:PEI-NPs were resuspended in fresh, GDNF-free spinal
cord media. This GDNF:PEI-NPs containing media was also
used for cultivation (thereafter resuspended GDNF:PEI-NPs).
Controls were fed with GDNF supplemented media (50 or
100 ng/ml) for the whole cultivation time and handled in
parallel.
Statistical analysis was performed using a One-Way-ANOVA
followed by a Bonferroni post-hoc analysis with p < 0.05 being
statistical significant.
Results
Approaches for NGF Functionalization: Covalent
and Non-covalent
The fluorescently labeled NGF and the functionalized NPs were
tested on PC12 cells as these possess specific cell surface receptors
that bind NGF. In presence of this growth factor, cells undergo a
dramatic change in phenotype wherein they acquire a large part
of the characteristic properties of sympathetic neurons. PC12
cells treated with 50 ng/ml of fluorescent NGF were found to
exhibit a phenotype similar to the cultures treated with 50 ng/ml
of NGF. In a previous study Western blot analysis showed an
upregulation of phosphorylated TrkA receptor expression by
NGF-β, fluorescent labeled NGF, and fluorescently labeled NGF
coupled PEI-NPs confirming this result (Riggio et al., 2014).
Experimental results revealed that the fluorescent NGF binds
the surface of the PEI-NPs at a ratio of 14 ± 3µg of
fluorescent NGF permg of PEI-NPs. No statistical difference
was found between non-covalent NGF:PEI-NPs and covalent
NGF-PEI-NPs (data not shown). PC12 cells were incubated with
reduced media modified with NGF:PEI-NPs or NGF-PEI-NPs
(NGF concentration 140 ng/ml, NP concentration 10µg/ml).
In Figure 1, PC12 cultures incubated with reduced media
(Figure 1A), reduced media and NGF (Figure 1B), reduced
media and NGF-PEI-NPs (Figure 1C), and reduced media and
NGF:PEI-NPs (Figure 1D) are shown. For NGF-PEI-MNPs,
a strong reduction of the neurite number and length was
observed compared to the control (NGF 140 ng/ml). Otherwise,
for NGF:PEI-NPs cell differentiation proceeded similarly to
the control cultures treated with NGF. Confocal imaging
FIGURE 1 | PC12 cells incubated for 72h with reduced media (A), reduced media modified with NGF (B), reduced media modified
with NGF-PEI-NP (C), or reduced media modified with NGF:PEI-NP (D) (20X). Confocal microscopy of PC12 cells after 72 h of incubation
with NGF:PEI-NPs is shown in (E). Actin staining reveals the presence of NPs (green) in cell body, the growth cone at the tip of the axons
of the differentiated cells (40X).
Frontiers in Neuroscience | www.frontiersin.org 6 September 2015 | Volume 9 | Article 305
Pinkernelle et al. Growth factors for nanoparticle functionalization
demonstrated that the NGF:PEI-NPs are strongly engulfed by
cells, being localized in both the cell body and neurite protrusions
(Figure 1E). Based on these results, we can conclude that the
covalent approach impairs the bio-functionality of the protein.
We postulate that the strong interaction between the particles
surface and NGF induce the protein wrapping/adsorption onto
the particle surface. This could strongly affect the protein
mobility, ultimately altering its 3D structure and the interaction
with the TrkA receptor. Based on these results, we considered
the non-covalent approach to be the most promising. Electron
microscopy confirmed that in presence of NGF:PEI-NPs, PC12
cells were properly differentiated. They exhibited long neurites,
which were well connected within the network (Figures 2A,B).
Figure 2C shows a representative cell with a cluster of NPs
bound to the cell surface, which is highlighted in Figure 2D.
EDX analysis revealed iron content and therefore confirmed the
NGF:PEI-NP–cell interaction (Figure 2E). FIB-SEM analysis of
milled PC12 cells, a technique that allows sectioning a cell and
acquiring information on the constitutive elements inside (Riggio
FIGURE 2 | SEM image of PC12 cells incubated 72h with NGF:PEI-NPs
(A–D). PC12 cells grew neurites confirming differentiation due to NGF (A–C).
Box in (C) points to NPs bound to the cell surface, (D) illustrates higher
magnification of NPs and area of EDX analysis shown in (E).
et al., 2014), illustrated the successful internalization of NGF:PEI-
NPs (Figures 3A,B,D). EDX analysis, shown in Figures 3C,E,
confirmed that internalized clusters seen in Figures 3A,B,D are
from iron and therefore iron oxide PEI-NPs.
Validation of Bio-functionality of GNDF:PEI-Nps
First, we tested for bio-functionality of GDNF:PEI-NPs after
coupling. For this, we analyzed the number of surviving motor
neurons in organotypic spinal cord cultures incubated with these
NPs instead of GDNF supplement via media. GDNF:PEI-NPs
were able to keep motor neuronal populations alive. There
were no significant differences in the total number of surviving
neurons or in the number of motor neurons between controls
containing 100 or 50 ng/ml GDNF in the media and GDNF:PEI-
NPs incubated cultures (Figures 4A,B). Parallel handled cultures
that were cultivated without GDNF supplement displayed
significantly less surviving neurons in the total number and in
the number of motor neurons than controls 100 (100 ng/ml
GDNF supplement). Figures 4C–E show corresponding
immunofluorescent stainings for anti-pan-neurofilament.
Controls and cultures, incubated with GDNF:PEI-NPs illustrated
a prominent motor neuronal population (Figures 4C,E).
Cultures without GDNF supplement displayed a clear reduction
of stained motor neurons (Figure 4D). Accordingly, GDNF
function was kept during coupling to the PEI-NPs.
The non-covalent approach was used to test the NP
functionalization with GDNF. Therefore, we checked the GDNF
coupling stability to the PEI-NPs. For this, organotypic cultures
were cultivated for 7 days and fed with media containing
100 ng/ml GDNF (control 100), 50 ng/ml GDNF (control 50,
reduced GDNF to compare with the lower GDNF concentration,
which is delivered by the GDNF:PEI-NPs), supernatant of
GDNF:PEI-NPs or resuspended GDNF:PEI-NPs.
GDNF:PEI-NPs were diluted in spinal cord media without
supplemented GDNF (NP concentration 10µg/ml, GDNF
concentration about 55 ng/ml) and incubated for 1 h at 4◦C.
Then, NPs were separated from media with a magnet and the
NPs were resuspended in fresh media without GDNF and used
for cultivation of the resuspended GDNF:PEI-NPs-group. The
supernatant, which was left after the magnetic separation, was
also used for cultivation (supernatant GDNF:PEI-NPs). GDNF
is required for the survival of the motor neuronal population in
the spinal cord cultures. Therefore, we quantified the number of
surviving motor neurons in both groups and compared them to
controls. If the number of motor neurons of the resuspended
GDNF:PEI-NPs-group was similar to the number of motor
neurons in the controls, then the GDNF was delivered by the
GDNF:PEI-NPs. But if the number of motor neurons of the
supernatant group were similar to that of the controls then
the GDNF was dissociated from the PEI-NPs and left in the
supernatant.
Figure 5 displays the result. Organotypic cultures incubated
with the supernatant of former diluted GDNF:PEI-NPs revealed
the same survival rate of the total number of neurons and the
motor neurons as was seen in the controls (Figures 5A,B). At
the same time, cultures that were cultivated with the resuspended
GDNF:PEI-NPs showed a significant decrease of the number of
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FIGURE 3 | FIB-SEM images of milled PC12 cells differentiated with NGF:PEI-NPs showing clear internalization of the NPs by PC12 cells
(A,B,D). In (B) one cluster of internalized NPs was chosen for EDX analysis illustrated in (C). EDX analysis revealed iron content of chosen cluster. (D)
displays alternative EDX analysis area including both seen NPs clusters. In (E) EDX analysis of this area is shown and reveals iron content of the
clusters confirming the internalization of iron oxide NPs.
FIGURE 4 | Analysis of GDNF-functionality of GDNF:PEI-NPs. Cultures were cultivated with GDNF supplemented to the media (100 or 50 ng/ml GDNF) as
controls, without any GDNF supplement or with GDNF:PEI-NPs in the media. The total number of neurons (A, mean ± SEM) decreased in cultures without
GDNF supplement, but there were no changes in the number of surviving neurons with incubation of GDNF:PEI-NPs compared to the controls. The same result
was found concerning the number of surviving motor neuron (B, mean ± SEM). Corresponding fluorescent anti-pan-neurofilament staining of control culture (C),
culture cultivated without GDNF (D) and culture with GDNF:PEI-NPs (E). Bars = 500µm. Significance differences are marked with * and demonstrate p < 0.05.
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FIGURE 5 | Analysis of coupling stability of GDNF to PEI-NPs in spinal cord cultures. Cultures were cultivated with GDNF supplemented to the media (100 or
50 ng/ml GDNF) as controls, with the supernatant of previous suspended GDNF:PEI-NPs (supernatant GDNF:PEI-NPs) or with resuspended GDNF:PEI-NPs in fresh
media. The total number of neurons (A, mean ± SEM) did not show significant differences, but the number of motor neurons (B) was significantly decreased in cultures
cultivated with resuspended GDNF:PEI-NPs compared to control (50 ng/ml GDNF). Corresponding fluorescent anti-pan-neurofilament stainings of control culture (C),
culture cultivated with supernatant of GDNF:PEI-NPs (D), and culture cultivated with GDNF:PEI-NPs (E). Bars = 500µm. Significance differences are marked with * and
demonstrate p < 0.05.
surviving motor neurons compared to control 50. Figures 5C–E
shows corresponding immunofluorescent stainings for anti-
pan-neurofilament. Controls and cultures incubated with the
supernatant of GDNF:PEI-NPs, but not with the particles
itself, illustrated a pronounced motor neuronal population
(Figures 5C,E). Cultures receiving resuspended GDNF:PEI-NPs
showed a clear reduction of stained motor neurons (Figure 5D).
So, GDNF bio-functionality did not correspond to the availability
of the GDNF:PEI-NPs. The GDNF coupling was not stable.
Discussion
Functionalization with NGF
Aim of this study was to functionalize magnetic NPs with
growth factors to facilitate a receptor-mediated intracellular
uptake into neurons. Enhanced neuronal uptake would allow the
magnetically targeted delivery of drugs and growth factors to
injury sites of the CNS and PNS.
There are only a few studies using growth factors to
functionalize NPs. Polak and Shefi (2015) published an overview
about growth factors used. Besides NGF, basic fibroblast growth
factor (FGF2), BDNF, and GDNF are reported.
To check the bio-functionality of growth factors after binding
toNPs a fast, easy, and reliablemodel is needed. In vitro assays are
the methods of choice because they require no or fewer animals,
are faster, and also cheaper than in vivomodels.
In our study, we first chose NGF for loading the self-made
magnetic PEI-NPs. For determining the bio-functionality of the
NGF loaded PEI-NPs, we used PC12 cells as indicator model.
PC12 cells can be differentiated with NGF into cells displaying
functions of sympathetic neurons. NGF-treated cells terminate
proliferation, develop neurites, become electrically excitable, and
express neuronal proteins like synapsin and growth associated
protein 43 (GAP43) (Greene and Tischler, 1976; Fujita et al.,
1989; Das et al., 2004). The outgrowth of neurites is used as a
differentiation marker because it is easy to quantify. PC12 cells
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are used in many studies concerning NPs and functionalization
of NPs, e.g., Pisanic et al. (2007) used PC12 cells to analyze
nanotoxicity of iron oxide NPs, Roy et al. (2010) used PC12 cells
to check for the targeting of NGF-conjugated NPs and evaluated
the expression levels of Trk- and p75-receptors, and Mittnacht
et al. (2010) functionalized siRNA for RhoA, a kinase playing a
role in neurite outgrowth.We started with a covalent approach to
bind NGF to the amine groups of PEI-NPs via EDAC chemistry.
Covalent binding worked, but obviously changed the structure of
NGF, as these NGF-PEI-NPs were not able to differentiate PC12
cells properly. It seems that the protein function was impaired by
covalent binding to PEI-NPs. NGF binds to its receptor TrkA via
N-terminal residues. The loops L2 and L4 of the protein structure
appear to be responsible for bio-functionality of NGF (Wiesmann
et al., 1999). The covalent binding of NGF to amine groups of the
PEI-NPs occurs randomly. Because we observed an impairment
of bio-functionality of NGF, it is possible that binding to
N-terminal residues or in the loops L2 and L4 took place.
Alternatively, we bound NGF using a non-covalent approach,
which is based on electrostatic interactions between molecules.
These NGF:PEI-NPs were able to differentiate PC12 cells to
neuronal cells. Functionality was maintained during binding to
the PEI-NPs. Interestingly, experimental data demonstrated that
the NGF:PEI-NPs complex is also stable when mixed to the cell
culture media, which indicates that non-specific adsorption of
plasma proteins does not alter the stability and the integrity of
the conjugate (Riggio et al., 2013).
Functionalization with GDNF
Additionally, we used GDNF for functionalization of our PEI-
NPs. GDNF was first described in 1993 by Lin et al. (1993) as a
growth promoting factor for embryonic midbrain dopaminergic
neurons. Since then, it was shown that GDNF also promotes the
survival of dopaminergic neurons in rodents and non-human
Parkinson models (Gash et al., 1998), that it can prevent the
programmed cell death of motor neurons during embryonic
development (Oppenheim et al., 1995), and that GDNF increases
survival and neurite sprouting in models of spinal cord injury
(Li et al., 1995; Pajenda et al., 2014). GDNF also has non-
neurotrophic functions: it regulates the ureteric branching during
embryogenesis (Vega et al., 1996) and spermatogenesis (Meng
et al., 2000). The various functions of GDNF limit the choice
of useful in vitro models. One model that allows analyzing the
GDNF functionality fast and reliably is the organotypic culture
of dorsal root ganglions. The group of Ziv-Polat et al. (2014)
measured sprouting and the onset of myelination to evaluate
GDNF function. In contrast, we used a neonatal organotypic
spinal cord culture to assess the bio-functionality of GDNF. In
such cultures, GDNF is known to be a prominent neurotrophic
factor for motor neuronal survival, as it is able to keep about
60% of the motor neurons alive during cultivation (Rakowicz
et al., 2002; Vyas et al., 2010). Therefore, quantifying the number
of surviving motor neurons after a sufficient cultivation time
already allows one to judge the successful functionalization
of NPs.
Based on our previous results of NGF coupling to PEI-NPs,
we decided to use a non-covalent approach to bind GDNF to
our PEI-NPs. To check the functionality of the bound GDNF, we
cultivated our organotypic spinal cord cultures with GDNF:PEI-
NPs only and compared the number of surviving motor neurons
and the total number of neurons after 7 days of cultivation.
Compared to control cultures, which received GDNF via media,
cultures incubated with GDNF:PEI-NPs showed a similar total
number of surviving neurons and also motor neurons at the end
of the cultivation. Therefore, GDNF function was kept during
coupling to PEI-NPs. Because of the 3-dimensional structure
of the organotypic culture, visualizing an uptake of GDNF:PEI-
NPs into neurons is difficult. Moreover the use of serum-high
media for the cultivation of organotypic spinal cord cultures
can cause problems because the NPs become surrounded by a
protein corona (Lundqvist et al., 2008). Thus, we tried to confirm
the stability of the non-covalent binding of GDNF to the PEI-
NPs. According to the protocol already used to test the stability
of NGF:PEI-NPs in biological media (Riggio et al., 2013), we
incubated the GDNF:PEI-NPs in the serum-rich media for these
cultures. After separating these NPs with a strong magnet, we
used either the supernatant of the NPs for cultivation of the spinal
cord cultures or resuspended them again in GDNF-free, fresh
media and used this for the cultivation. If now the number of
surviving motor neurons in cultures incubated with resuspended
GDNF:PEI-NPs was similar to the number of surviving motor
neurons in controls (receiving GDNF via media), the GDNF
functionality was kept by the GDNF:PEI-NPs. If the number
of surviving motor neurons in cultures cultivated with the
supernatant (no GDNF:PEI-NPs left) was similar to the number
of surviving motor neurons of the controls, the GDNF bio-
functionality passed on to the media. In our study, the number of
surviving motor neurons was not significantly different between
controls and cultures incubated with the supernatant. But it
decreased significantly in cultures cultivated with resuspended
GDNF:PEI-NPs compared to controls. Therefore, the GDNF
bio-functionality was kept in the supernatant and the GDNF
separated from the PEI-NPs.
In contrast, non-covalently NGF:PEI-NPs were found to be
stable in binding. They were up taken into PC12 cells and induced
a differentiation of PC12 cells. One main difference between the
media of PC12 cells and organotypic spinal cord cultures is the
amount of serum. Spinal cord culture media contains 25% FBS
compared to the 2% used in the media for differentiation of PC12
cells. As alreadymentioned, NPs are coated with a protein corona
in serum-containing media (Lundqvist et al., 2008; Calatayud
et al., 2014). The protein corona contains a variety of proteins
like immunoglobulins, albumin, apolipoproteins, fibrinogen, and
many more (Lundqvist et al., 2008). Non-covalent coupling
of GDNF to PEI-NPs is not a fixed coupling; it is based on
electrostatic interactions between residues of molecules. These
interactions are weaker than covalent interactions where atoms
share electrons. Due to the high serum content in the spinal
cord media, it can be assumed that the protein corona is more
pronounced than in the low-serummedia of the PC12 cells. Thus,
serum proteins and GDNF appear to compete for binding, which
results in a loss of GDNF bound to PEI-NPs.
The group of Ziv-Polat et al. (2014) compared the bio-
functionality of NGF, FGF2, and GDNF conjugated to iron oxide
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NPs. They showed that the conjugated neurotrophic factors
were more stable and also the bio-functionality of the growth
factors increased significantly. In particular, GDNF bound to
the NPs enhanced the myelination in their organotypic dorsal
root ganglion model. To conjugate all 3 neurotrophic factors,
Ziv-Polat et al. (2014) used a covalent approach via activated
double bonds of dextran- or gelatin-coated NPs. Also Marcus
et al. (2015) used a covalent binding strategy to bind NGF to
human serum albumin-coated iron oxide NPs. They successfully
induced the differentiation of PC12 cells in a neuronal-like cell
type, thereby proving the bio-functionality of NGF-HSA-NPs. In
our experiments, covalently binding was shown to impair the bio-
functionality of NGF.We used PEI-coated iron oxide NPs, which
allow binding covalently proteins via amine groups. Obviously,
binding proteins covalently to NPs is dependent on the chosen
chemical strategy. Interactions between proteins and NPs are
hardly predictable and since the exact binding site in the structure
of the protein is somehow random, the outcome regarding
the bio-functionality seems to be random as well. Even if the
catalytic site is not involved in chemical binding, the overall 3D
structure of the protein could be affected by the strong chemical
bonding with the particle, resulting in structural deformation,
and loss of function. Designed, small peptides could help to
solve these issues and prevent unintentional binding effects
and loss of functionality. Alternative approaches already tried
to develop small peptides mimicking growth factor functions.
Smaller peptides have certain advantages in comparison to
native proteins. Growth factors address various signal pathways
leading to a variation of actions which can include unintentional
effects, too (Boyd and Gordon, 2003). GDNF overexpression
during embryogenesis, for example, is preventing naturally
occurring programmed cell death of motor neurons leading to
hyperinnervation of muscles (Zwick et al., 2001). Small peptides
which are designed with special functional sites give the chance to
generate distinct signaling profiles. Forte et al. (2014) described
the binding of 2 growth factor mimicking peptides, NGF (1–14)
and BDNF (1–12) on a gold carrier, a chemistry which can be
used to conjugate to, e.g., gold nanoparticles. Previously, the same
group reported biological actions of a NGF (1–14) peptide which
could activate single intracellular signal cascades in PC12 cells
(Travaglia et al., 2015). Bradley et al. (2010) specified another
synthetic peptide showing GDNF functions. This peptide DNSP-
11from the proGDNF-domain was shown to support neuronal
survival and neuritic outgrowth in vitro, but also increasing
dopamine levels in an animal model of Parkinson disease.
Taken together, we could show that functionalization of
NPs with growth factors can be complex and difficult.
Functionalization of PEI-NPs with NGF using covalent and
non-covalent binding strategies displayed contrasting results.
Covalently bound NGF-PEI-NPs were not able to differentiate
PC12 cells, proving a lack of bio-functionality after binding.
Non-covalent bound NGF:PEI-NPs differentiated PC12 cells into
neuronal-like cells, thereby showing bio-functionality of NGF.
Due to the experiences of NGF-functionalization, we used a
non-covalent approach for functionalization of PEI-NPs with
GDNF. This was shown to keep bio-functionality of GDNF in
an organotypic spinal cord model, but was additionally found to
be unstable bound to the PEI-NPs. We suspect that the different
serum content in the media of PC12 cells and organotypic spinal
cord cultures is a problem for using non-covalent approaches.
All in all, our study shows the importance of checking the bio-
functionality of growth factors bound to NPs with a proper
biological model. The final future aim of all studies using NPs
in life sciences is to use these particles in humans. For this, it is
important to develop reproducible models that allow a prognosis
of NPs action in vivo.
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